Neutrophil–lymphocyte ratio predicts overall and recurrence‐free survival after liver transplantation for hepatocellular carcinoma. Issue 7 (30th November 2012)
- Record Type:
- Journal Article
- Title:
- Neutrophil–lymphocyte ratio predicts overall and recurrence‐free survival after liver transplantation for hepatocellular carcinoma. Issue 7 (30th November 2012)
- Main Title:
- Neutrophil–lymphocyte ratio predicts overall and recurrence‐free survival after liver transplantation for hepatocellular carcinoma
- Authors:
- Limaye, Alpna R.
Clark, Virginia
Soldevila‐Pico, Consuelo
Morelli, Giuseppe
Suman, Amitabh
Firpi, Roberto
Nelson, David R.
Cabrera, Roniel - Abstract:
- <abstract abstract-type="main"> <title> <x xml:space="preserve">Abstract</x> </title> <sec id="hepr12019-sec-0001" sec-type="section"> <title>Aim</title> <p>The goal of this study is to evaluate whether an elevated neutrophil–lymphocyte ratio (NLR) at the time of diagnosis predicts survival of patients with hepatocellular carcinoma (HCC) after liver transplantation (LT). We hypothesize that the NLR is predictive of overall survival (OS) and recurrence‐free survival (RFS) in patients with HCC who undergo LT.</p> </sec> <sec id="hepr12019-sec-0002" sec-type="section"> <title>Methods</title> <p>This is a retrospective analysis of adult patients undergoing LT for HCC between 2000 and 2008 at our institution. We define an elevated NLR as a ratio of 5 or greater.</p> </sec> <sec id="hepr12019-sec-0003" sec-type="section"> <title>Results</title> <p>We included 160 patients who underwent LT for HCC in the time period, of whom 28 had an elevated NLR. Seventeen subjects experienced recurrent HCC during the study period. The cumulative survival among subjects with an elevated NLR was significantly lower than among subjects with a normal NLR. On univariate analysis, several factors (including an elevated NLR) predicted decreased OS and RFS. However, after multivariate analysis, only three factors (including elevated NLR) remained significant as predictors of OS. Additionally, multivariate analysis revealed that an elevated NLR was the only significant independent predictor of RFS.</p><abstract abstract-type="main"> <title> <x xml:space="preserve">Abstract</x> </title> <sec id="hepr12019-sec-0001" sec-type="section"> <title>Aim</title> <p>The goal of this study is to evaluate whether an elevated neutrophil–lymphocyte ratio (NLR) at the time of diagnosis predicts survival of patients with hepatocellular carcinoma (HCC) after liver transplantation (LT). We hypothesize that the NLR is predictive of overall survival (OS) and recurrence‐free survival (RFS) in patients with HCC who undergo LT.</p> </sec> <sec id="hepr12019-sec-0002" sec-type="section"> <title>Methods</title> <p>This is a retrospective analysis of adult patients undergoing LT for HCC between 2000 and 2008 at our institution. We define an elevated NLR as a ratio of 5 or greater.</p> </sec> <sec id="hepr12019-sec-0003" sec-type="section"> <title>Results</title> <p>We included 160 patients who underwent LT for HCC in the time period, of whom 28 had an elevated NLR. Seventeen subjects experienced recurrent HCC during the study period. The cumulative survival among subjects with an elevated NLR was significantly lower than among subjects with a normal NLR. On univariate analysis, several factors (including an elevated NLR) predicted decreased OS and RFS. However, after multivariate analysis, only three factors (including elevated NLR) remained significant as predictors of OS. Additionally, multivariate analysis revealed that an elevated NLR was the only significant independent predictor of RFS.</p> </sec> <sec id="hepr12019-sec-0004" sec-type="section"> <title>Conclusion</title> <p>Preoperative NLR is a powerful independent predictor of OS and RFS in patients undergoing LT for HCC. Measurement of NLR could serve as a useful and easily obtained adjunct to the Model for End‐Stage Liver Disease score and Milan criteria when evaluating this patient population and determining which patients will gain the most survival benefit from transplantation.</p> </sec> </abstract> … (more)
- Is Part Of:
- Hepatology research. Volume 43:Issue 7(2013:Jul.)
- Journal:
- Hepatology research
- Issue:
- Volume 43:Issue 7(2013:Jul.)
- Issue Display:
- Volume 43, Issue 7 (2013)
- Year:
- 2013
- Volume:
- 43
- Issue:
- 7
- Issue Sort Value:
- 2013-0043-0007-0000
- Page Start:
- 757
- Page End:
- 764
- Publication Date:
- 2012-11-30
- Subjects:
- Liver -- Diseases -- Periodicals
Liver Diseases -- Periodicals
Foie -- Maladies -- Périodiques
616.362 - Journal URLs:
- http://www.sciencedirect.com/science/journal/09284346 ↗
http://firstsearch.oclc.org/journal=1386-6346;screen=info;ECOIP ↗
http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1872-034X ↗
http://www.sciencedirect.com/science/journal/13866346 ↗
http://www3.interscience.wiley.com/journal/118507311/home ↗
http://www.blackwell-synergy.com/rd.asp?goto=journal&code=hep ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/hepr.12019 ↗
- Languages:
- English
- ISSNs:
- 1386-6346
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4295.845000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 4238.xml